Analysis of streptococcal CRISPRs from human saliva reveals substantial sequence diversity within and between subjects over time - PubMed (original) (raw)

Analysis of streptococcal CRISPRs from human saliva reveals substantial sequence diversity within and between subjects over time

David T Pride et al. Genome Res. 2011 Jan.

Abstract

Viruses may play an important role in the evolution of human microbial communities. Clustered regularly interspaced short palindromic repeats (CRISPRs) provide bacteria and archaea with adaptive immunity to previously encountered viruses. Little is known about CRISPR composition in members of human microbial communities, the relative rate of CRISPR locus change, or how CRISPR loci differ between the microbiota of different individuals. We collected saliva from four periodontally healthy human subjects over an 11- to 17-mo time period and analyzed CRISPR sequences with corresponding streptococcal repeats in order to improve our understanding of the predominant features of oral streptococcal adaptive immune repertoires. We analyzed a total of 6859 CRISPR bearing reads and 427,917 bacterial 16S rRNA gene sequences. We found a core (ranging from 7% to 22%) of shared CRISPR spacers that remained stable over time within each subject, but nearly a third of CRISPR spacers varied between time points. We document high spacer diversity within each subject, suggesting constant addition of new CRISPR spacers. No greater than 2% of CRISPR spacers were shared between subjects, suggesting that each individual was exposed to different virus populations. We detect changes in CRISPR spacer sequence diversity over time that may be attributable to locus diversification or to changes in streptococcal population structure, yet the composition of the populations within subjects remained relatively stable. The individual-specific and traceable character of CRISPR spacer complements could potentially open the way for expansion of the domain of personalized medicine to the oral microbiome, where lineages may be tracked as a function of health and other factors.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Rarefaction analysis of CRISPR spacers in the saliva of human subjects at each sampled time point. Rarefaction curves were created using 10,000 random iterations based on spacer richness. (A) Subject #1; (B) subject #2; (C) subject #3; (D) subject #4. (Open circle) Month −6; (open square) Month −3; (closed triangle) Day 1; (closed square) Day 30; (closed circle) Day 60; (open triangle) Month 11.

Figure 2.

Figure 2.

Heatmap of unique spacers present in each subject at all time points. Each row represents a unique spacer sequence. The intensity scale bar is located to the right.

Figure 3.

Figure 3.

Shared CRISPR spacers in the saliva of individual human subjects at each time point. (A) Subject #1; (B) subject #2; (C) subject #3; (D) subject #4. (Gray) The proportion of spacers shared with other time points within each subject; (black) spacers that are unique to each time point within each subject.

Figure 4.

Figure 4.

Principal coordinates analysis of CRISPR spacer composition from human saliva based on beta diversity. (Gray triangles) Subject #1; (gray squares) subject #2; (black circles) subject #3; (black diamonds) subject #4.

Figure 5.

Figure 5.

Heatmap of bacterial OTU abundance based on analysis of 16S rRNA gene sequences from each of the samples and subjects. OTUs were determined by phylogenetic analysis of 16S rRNA sequence alignments, using a 97% cutoff value. Each row represents a unique OTU sequence based on the cutoff criterion. The intensity scale bar is located to the right. Taxonomic labels are shown along the _y_-axis, with OTUs from the genus Streptococcus indicated with a blue brace.

Figure 6.

Figure 6.

Principal coordinates analysis of OTU composition based on 16S rRNA gene sequence data from the saliva of each subject. Input to the analysis was beta unweighted unifrac distances. (Gray triangles) Subject #1; (gray squares) subject #2; (black circles) subject #3; (black diamonds) subject #4.

Figure 7.

Figure 7.

Streptococcus species in human subject saliva at each time point. Each species is displayed as a percentage of the total number of OTUs identified taxonomically to the Streptococcus genus. (A) Subject #1; (B) subject #2; (C) subject #3; (D) subject #4.

Figure 8.

Figure 8.

Pearson correlation scores for comparisons between CRISPR spacer content and streptococcal species composition. Intrasubject comparisons: (open squares) subject #1, (gray triangles) subject #2, (open circles) subject #3, (gray diamonds) subject #4; (black circles) intersubject comparisons.

Figure 9.

Figure 9.

Structure of a CRISPR locus from subject #2 at different time points. 2Mut38 represents an isolate of S. sanguinis from subject #2 recovered at Month 11.

Similar articles

Cited by

References

    1. Andersson AF, Banfield JF 2008. Virus population dynamics and acquired virus resistance in natural microbial communities. Science 320: 1047–1050 - PubMed
    1. Angly FE, Felts B, Breitbart M, Salamon P, Edwards RA, Carlson C, Chan AM, Haynes M, Kelley S, Liu H, et al. 2006. The marine viromes of four oceanic regions. PLoS Biol 4: e368 doi: 10.1371/journal.pbio.0040368 - PMC - PubMed
    1. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB 2009. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367–2375 - PMC - PubMed
    1. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315: 1709–1712 - PubMed
    1. Bik EM, Long CD, Armitage GC, Loomer P, Emerson J, Mongodin EF, Nelson KE, Gill SR, Fraser-Liggett CM, Relman DA 2010. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J 4: 962–974 - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources